Co-Amoxiclav Injection BP 1.2gm is a powerful sterile antibiotic formulation designed for intravenous use in critical healthcare situations. It combines Amoxicillin Sodium BP equiv...

Co-Amoxiclav Injection BP 1.2gm is a powerful sterile antibiotic formulation designed for intravenous use in critical healthcare situations. It combines Amoxicillin Sodium BP equivalent to 1000mg Amoxicillin and Potassium Clavulanate BP equivalent to 200mg Clavulanic Acid, creating a synergistic effect that counters bacterial resistance mechanisms. Manufactured under stringent aseptic conditions, it ensures purity, stability, and immediate therapeutic action upon administration. This injection is especially effective against beta-lactamase-producing bacterial strains, offering a dependable solution for clinicians managing resistant infections where conventional antibiotics prove ineffective. The product meets BP standards, providing consistent dosage accuracy, sterility, and pharmaceutical integrity for safe patient use.

This injection is widely employed across hospitals, intensive care units, surgical centers, and emergency departments to address serious bacterial infections. Key sectors utilizing this product include multi-specialty healthcare facilities, government hospitals, private nursing homes, and defense medical services. It is also supplied to pharmaceutical distributors and wholesalers catering to institutional buyers in the medical and healthcare fields. Its applications cover critical care medicine, surgery, gynecology, urology, and pulmonology, where swift and effective bacterial eradication is essential to prevent complications and support patient recovery. The product fulfills the rigorous demands of contemporary medical practice, aiding clinicians in achieving favorable patient outcomes.

Organizations sourcing Co-Amoxiclav Injection BP 1.2gm gain from its established reliability, regulatory compliance, and immediate readiness for clinical deployment. Its high efficacy shortens treatment duration, reduces hospital stays, and decreases overall healthcare expenses, delivering substantial value to medical institutions. The product's quality assurance, batch consistency, and sterility make it a trusted option for importers, distributors, and wholesalers serving clients in the healthcare sector. This injection distinguishes itself through clinical effectiveness, safety profile, and alignment with global treatment guidelines, positioning it as a preferred antibiotic solution worldwide.

Key Features:
- Contains Amoxicillin 1000mg and Clavulanic Acid 200mg per vial
- Sterile formulation compliant with BP standards
- Broad-spectrum activity against beta-lactamase-producing bacteria
- Ready for intravenous administration after reconstitution
- Manufactured under strict aseptic conditions for safety and efficacy

Benefits:
- Rapid and effective treatment of severe bacterial infections
- Reduces hospital stay duration and overall healthcare costs
- Trusted quality and batch-to-batch consistency
- Compliance with international pharmacopeial standards
- Supports positive patient outcomes in critical care settings